Prednesol 5mg Tablets

DRUG2 trials

Sponsors

Xentria Inc.

Conditions

Pulmonary sarcoidosis with or without extrapulmonary manifestations

Phase 1

A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without extrapulmonary manifestations

WithdrawnCTIS2022-502877-41-00

Xentria Inc.Pulmonary sarcoidosis with or without extrapulmonary manifestations

Target: 47Updated: 2023-09-04

A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without extrapulmonary manifestations

RecruitingCTIS2022-502877-41-01

Xentria Inc.Pulmonary sarcoidosis with or without extrapulmonary manifestations

Start: 2025-02-10Target: 24Updated: 2025-07-18